Project Grant R44CA310355
Award Date 9/12/25
Completion Date 8/31/27
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94301, USA
Similar Awards
- The National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), awarded a $225,229 Project Grant to Navigation Sciences Inc. on September 19, 2025. The grant will fund the development of a novel navigation software system, EndonaviSCI, to address key challenges in lung cancer surgery. The EndonaviSCI system aims to: 1) Ensure accurate localization and placement of a wireless electromagnetic sensor (J-bar) next to the tumor without the need for...
- This Project Grant award from the National Science Foundation (NSF), under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, supports the development and validation of a novel, projection-based surgical navigation platform by Illuminant Surgical Inc. The $274,865 award, effective January 15, 2024, aims to create a system that projects visual anatomical references and guidance directly onto a patient's skin during minimally invasive spinal procedures. This is expected to...
- This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,491 to Northridge Tri-Modality Imaging Inc. to upgrade their gantry-based imaging system to incorporate bioluminescence tomography (BLT) capabilities. The upgraded system will enable 3D whole-body fluorescent, bioluminescent, and anatomical X-ray imaging of small animal cancer models, providing a comprehensive multimodal imaging...
- This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $1,116,368 to develop a novel visualization, labeling, and tracking engine for human anatomy to enhance the standardization, precision, and communication of skin cancer data. The project aims to create methods to document reproducible and standardized anatomic site descriptions of skin cancer locations, visualize skin cancer locations, and attach...
- This Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $978,154 to Surgivance Inc. to further develop a digital pathology "laboratory-in-a-box" solution that produces and analyzes high-resolution, 3D digital pathology images at the point of care within seconds. The solution combines rapid confocal imaging hardware with AI-enabled software to automatically recolorize and interpret the digital...
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) in the amount of $399,112 will be used by Imvaria Inc. to adapt its fully automated, AI-powered "DigitalBX" diagnostic tool for analyzing chest CT scans to detect pulmonary nodules suspicious of lung cancer. The goal is to provide an end-to-end automated diagnostic solution implemented as a secure cloud-based application that is fully reimbursable, alleviating the cost...
- This federal Project Grant award of $374,095 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a device that uses an infrared laser to enable local delivery of a high dose of chemotherapy to the surgical cavity after tumor resection. The technology employs thermosensitive liposomal nanoparticles encapsulating chemotherapy agents that...
- This National Science Foundation (NSF) Cooperative Agreement award of $1,250,000 to Illuminant Surgical Inc., a minority-owned small business in Palo Alto, CA, is focused on developing a novel surgical navigation technology for minimally invasive spine procedures. The project aims to commercialize a camera-projector system that can project medical images and surgical guidance information directly onto a patient's body in real-time, enabling improved surgical accuracy and reduced complications....
- Visikol Inc. received a $4,103,265 Project Grant award from the National Cancer Institute, a division of the Department of Health and Human Services, under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The award will support the development of a 3D imaging diagnostic tool to improve characterization of metastatic melanoma in sentinel lymph node biopsies. Visikol will conduct a retrospective clinical study using archived negative sentinel lymph node biopsy tissue blocks to...
- This Project Grant award of $306,798 from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop an artificial intelligence-based system to accurately identify malignant lymph nodes. The key objectives are to: Create a lymph node segmentation model to enable extraction of radiomic features critical for malignancy classification. Develop both cloud-based and standalone desktop deployment options for the classification model to...